108 related articles for article (PubMed ID: 7909153)
1. Loss of heterozygosity and overexpression of the p53 gene in ovarian carcinoma.
Frank TS; Bartos RE; Haefner HK; Roberts JA; Wilson MD; Hubbell GP
Mod Pathol; 1994 Jan; 7(1):3-8. PubMed ID: 7909153
[TBL] [Abstract][Full Text] [Related]
2. p53 expression, mutation, and allelic deletion in ovarian cancer.
McManus DT; Yap EP; Maxwell P; Russell SE; Toner PG; McGee JO
J Pathol; 1994 Nov; 174(3):159-68. PubMed ID: 7823248
[TBL] [Abstract][Full Text] [Related]
3. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
Okamoto A; Sameshima Y; Yokoyama S; Terashima Y; Sugimura T; Terada M; Yokota J
Cancer Res; 1991 Oct; 51(19):5171-6. PubMed ID: 1680546
[TBL] [Abstract][Full Text] [Related]
4. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
5. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
[TBL] [Abstract][Full Text] [Related]
6. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.
McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG
J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
Semczuk A; Marzec B; Skomra D; Roessner A; Cybulski M; Rechberger T; Schneider-Stock R
Oncology; 2005; 69(4):317-25. PubMed ID: 16293976
[TBL] [Abstract][Full Text] [Related]
9. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between mutation of tumor suppressor gene p53 and development of hepatocellular carcinoma].
Zhu MH
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):245-7. PubMed ID: 7909744
[TBL] [Abstract][Full Text] [Related]
11. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP.
Chen YH; Li CD; Yap EP; McGee JO
J Pathol; 1995 Oct; 177(2):129-34. PubMed ID: 7490678
[TBL] [Abstract][Full Text] [Related]
12. An uncertain role for p53 gene alterations in human prostate cancers.
Brooks JD; Bova GS; Ewing CM; Piantadosi S; Carter BS; Robinson JC; Epstein JI; Isaacs WB
Cancer Res; 1996 Aug; 56(16):3814-22. PubMed ID: 8706029
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
14. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx.
Maestro R; Dolcetti R; Gasparotto D; Doglioni C; Pelucchi S; Barzan L; Grandi E; Boiocchi M
Oncogene; 1992 Jun; 7(6):1159-66. PubMed ID: 1594246
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
16. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
Sakamoto T; Nomura N; Mori H; Wake N
Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
[TBL] [Abstract][Full Text] [Related]
18. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC
Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830
[TBL] [Abstract][Full Text] [Related]
19. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and mutation of p53 in epithelial ovarian cancer.
Marks JR; Davidoff AM; Kerns BJ; Humphrey PA; Pence JC; Dodge RK; Clarke-Pearson DL; Iglehart JD; Bast RC; Berchuck A
Cancer Res; 1991 Jun; 51(11):2979-84. PubMed ID: 2032235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
